Cardiac fibrosis after primary infarction is a type of pathological phenomena as shown by increased collagen in myocardial cells. Transforming growth factor (TGF)-b1 is a critical factor participating in myocardial fibrosis.
Background
Cardiovascular disease severely affects public health. Myocardial fibrosis is a pathology abnormality caused by increased collagen in cardiomyocytes. The fibrosis of myocardial tissue may lead to heart dilation, and decreased heart compliance, eventually leading to heart failure [1] . In cardiac infarction tissue, it is common to find the synthesis and deposition of multiple extracellular matrix. After several months or even years after cardiac infarction, such extracellular matrix is still in active status. Therefore, the successful management of the progression of cardiac fibrosis can significantly improve the prognosis of patients.
Various signal molecules are involved in the progression of cardiac fibrosis. For example, interleukin-1 (IL-1) and angiotensin II (Ang-II) can stimulate the differentiation of cardiac fibroblasts into muscle-like fibroblasts, which has potent ability for proliferation, migration, and collagen secretion [2] . Transforming growth factor b1 (TGF-b1) is an important member of the TGF-b family, is important for mediating cell growth and differentiation, and plays an important role in the occurrence and progression of multiple diseases. Present in multiple tissues, TGF-b1 can be secreted by various somatic cells, such as cellular secretions during inflammation. TGF-b1 induces synthesis and deposition of extracellular matrix, and participates in the occurrence of fibrosis in various tissues. A previous study reported the involvement of TGF-b1 in the fibrosis of multiple organs, such as heart, kidney, and liver [3] . TGF-b can activate transcriptional factor SMAD4, which further elevates Fn14 expression for the participation of extracellular matrix and activation of fibroblast [4] . TGF-b1 can facilitate the activation and collagen secretion of myocardial fibroblasts involved in the progression of cardiac fibrosis along with other risk factors [5] . For example, connective tissue growth factor (CTGF) is abnormally enhanced in the progression of cardiac fibrosis, largely due to induction by TGF-b1. Moreover, TGF-b1 plays a crucial role in the differentiation of cardiac fibrosis via regulating FoxO1 gene [6] .
MicroRNA (miR) is a type of non-coding RNA molecule with 19~25 nucleic acid length. It can bind with 3'untranslational region (3'-UTR) to cause mRNA degradation or translational inhibition, both of which modify target gene expression and thus participate in occurrence and progression of various diseases. The highly conserved sequence during evolution and specific expression depending on the disease course endow the potency of miR as a predictive factor for classification and treatment target of various genes. Various studies showed the involvement of miR in cardiac fibrosis. For example, miR-29 can regulate collagen synthesis by inhibiting the synthesis of collagen to retard the progression of myocardial infarction [7] . miR-30 and miR-133 can decrease collagen synthesis via regulating CTGF expression [8] , and miR-34a can regulate the fibrosis after myocardial infarction via targeting Smad4 [9] . MiR-24 is a hypoxia-sensitive miR in vascular endothelial cells, and is involved in cardiac vascular changes after infarction [10] . The enhancement of miR-24 expression can decrease the function of smooth muscle cells [11] .
A previous study showed that Furin regulated the activation of TGF-b via angiotensin II (ANGII) [12] , and a recent study revealed that Furin exerted its functions via facilitating TGF-b activation [13, 14] . In other studies using cardiac fibroblasts of neonatal mice, miR-24 exerted its function via targeting Furin and hence inhibiting TGF-b1 activation. The present study thus investigated the role of miR-24 and Furin/TGF-b1 in rat myocardial fibrosis.
Material and Methods

Reagent and equipment
We used the following reagents and equipment: Real-time fluorescent quantitative RT-PCR kit (TaKaRa, Japan); TRIzol reagent (Invitrogen), ABI 7500 fluorescent quantitative PCR cycler (Applied Biosystem, USA); High-speed cold centrifuge (Eppendorf, USA); SYBR Green qPCR mix (ToYoBo, Japan); Hematoxylin-eosin dye (Qiyi Bio, China); Protein electrophoresis and transfer apparatus (Invitrogen, USA); and BCA protein quantification kit (Sigma-Aldrich, USA).
Animals and cardiac infarction model
We used 40 healthy SPF grade SD adult rats (20 males and 20 females, provided by Shangdong University) with body weight between 200 and 280 g. After anesthesia (intraperitoneal injection) by 10% chloral hydrate, tracheal intubation was performed before exposing the heart. The descending branch of the left coronary artery was blocked for 6 s to whiten the myocardial tissue below, accompanied with elevated S-T segment on ECG. Chest walls were sutured by layers. Rats were then randomly assigned into 4 groups (N=10 each). The sham group consisted of rats that underwent the surgery but without ligation, while the other 30 rats were killed at 1 week, 2 weeks, and 4 weeks after surgery (N=10, 9, and 9, respectively). Tissues samples were obtained at 3 times points, while control rats were killed and harvested at 4 weeks.
Rats were used for all experiments, and all procedures were approved by the Animal Ethics Committee of Shandong Provincial Qianfoshan Hospital. dye was added after re-hydration, followed by eosin staining. Tissue sections were mounted with coverslips and observed under a light field microscope.
Cardiac tissue RNA extraction
Harvested myocardial tissues were homogenized in liquid nitrogen and lysed in TRIzol reagent. Phenol-chloroform was used to extract total RNA, which was re-suspended in DEPCtreated water. UV spectrometry was employed to determine the purity and concentration of RNA, whose integrity was determined in 1% agarose gel electrophoresis. RNA was stored at -80°C for further use.
Real-time PCR for mRNA levels of miR-24, Furin, and TGF-b1
The TaKaRa reverse transcription kit was used to synthesize DNA using miRNA-24, Furin, and TGF-b1 mRNA following the manual's instructions. The PCR system (total 20 μl) consisted of 9 μl 2XSYBR Green Mixture; 2 μl Primer 1 (5 μM); 2 μl Primer 2 (5 μM); 2 μl cDNA, and 5 μl ddH 2 
Western blotting for protein levels of Furin and TGF-b1
Myocardial tissues were homogenized and mixed with protein lysis buffer. At 4°C, the mixture was vibrated every 5 min (1 min each) for 5 times, followed by 12 000 rpm centrifugation for 20 min. The supernatant was saved protein quantification using the BCA kit. We loaded 50 ng proteins and separated them in SDS-PAGE under a 40-V electrical field. After 5 h, proteins were transferred to the membrane under 60V for 2h, followed by Ponceau red staining for 5 min. The membrane was then blocked, and incubated in primary and secondary antibody for developing. The film was scanned for analysis.
Statistical methods
The SPSS13.0 software package was used in statistical analysis and the t test was employed in 2-sample independent tests. Enumeration data were compared by chi-square test.
Pearson correlation was performed to analyze the relationship between expression of miR-24, Furin, or TGF-b1 with cardiac function parameters. A significant level was defined as 0.05.
Results
Pathology of rat myocardial tissues
By HE staining, we observed the dynamic change of rat myocardial tissues within 4 weeks of cardiac infarction (Figure 1 ). In the control group, cells were arranged regularly, with clear and sharp muscle stripes, without significant numbers of inflammatory cells. At the first and second week of myocardial infarction, the boundary between myocardial cells disappeared, with abundant inflammatory cells and monocytes infiltration. After 4 weeks, it was clear that increasing connective tissues existed and widened the intra-myocardial cleft, accompanied with more inflammatory cells and fibroblasts. Masson staining demonstrated the longer time after myocardial infarction, and the increased collagen fibrils in the outer spaces ( Figure 2 ).
mRNA expression level of miR-24, Furin, and TGF-b1
Real-time PCR results showed significantly decreased miR-24 at 2 and 4 weeks after myocardial infarction. With prolonged time of infarction, miR-24 level was progressively down-regulated. mRNA levels of Furin and TGF-b1 were, however, elevated at 2 and 4 weeks after infarction, when compared to those in the control group (p<0.05, Figure 3 ), suggesting that miR-24, Furin, and TGF-b1 are involved in the formation of myocardial fibrosis.
Furin and TGF-b1 protein levels in myocardial tissues
Western blotting results showed that longer time after myocardial infarction was associated with higher Furin and TGF-b1 protein levels. A significant increase was observed at 4 weeks after myocardial infarction, as Furin and TGF-b1 shared consistent patterns. 
Discussion
The most abundantly distributed cell type inside cardiac tissues is myocardial fibroblast, which, under normal physiological conditions, is at rest status. With certain pathological alternations, it can secrete high levels of collagen to damage cardiac functions [15] . The TGF-b1 signal pathway is important for myocardial fibrosis. A previous study showed the high expression of miR-24 in myocardial fibroblasts, which can affect the synthesis of extracellular matrix collagen, possibly via interfering with the TGF-b1 signal pathway via mediating Furin [16] . Another study also found the activation of TGF-b1 by Furin enhanced MMP-2 expression and further tumor cell invasion [17] .
The present study revealed significant myocardial fibrosis with prolonged time of infarction, as shown by connective tissues in the inter-myocardial fiber cleft, whose width was increased, with more inflammatory cells and fibroblasts, suggesting the successful preparation of this rat myocardial infarction mode, on which further experiments were performed.
In myocardial tissues of infarction rats, miR-24 level was gradually decreased with prolonged time of infarction. Furin, which is a possible target gene for miR-24, was also up-regulated, further supporting a previous study by Wang et al. [16] . A study showed the possible involvement of Furin in the regulation of multiple important TGF-b1 protein, such as lefty-1 and lefty-2 [18] . As a pluripotent miRNA, miR-124 is correlated with blood cell differentiation, tumor formation, cell proliferation, and differentiation [19] . In human liver cancer cells and skeletal muscle cells, miR-24 regulates the TGF-b signal pathway [20, 21] . The assay for mRNA expression level of TGF-b1 in myocardial tissues at different time points after infarction found the significant elevation of TGF-b1 mRNA at 2 weeks after myocardial infarction. Western blotting showed similar A previous study also revealed the thickening of myocardial muscle and mesenchymal fibrosis in TGF-b1-over-expressed mice [22] , while TGF-b1-deficient mice had significant improvement of cardiac compliance [23] . As TGF-b could facilitate myocardial fibrosis via stimulating the proliferation of fibroblast [24] , the inhibition of TGF-b1 expression in myocardial tissues could improve cardiac fibrosis.
Actually, the anti-fibrotic treatment after myocardial infarction including anti-TGF-b1 agent has been shown to decrease the infarction area [25] .
The Smads signal pathway is the major pathway participating in myocardial fibrosis [26] . The understanding of how Furin/TGF-b1 is involved in this process, however, is still incomplete. The present study has certain inherent limitations, 
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including the fact that a single miRNA molecule can modulate multiple target gene expressions, and a single gene can be mediated by various miRNA molecules. Further research in warranted on the role of miR-24 in the progression of myocardial fibrosis and whether miR-24 targets multiple genes, in order to provide more evidence for use in developing anti-fibrotic medicine. Results of this study provide new insights for illustrating the role of Furin/TGF-b1 signal pathway in the process of myocardial fibrosis and related mechanisms.
